Savant HWP - 18-MC Drug - Ownership and Business Overview

Life ScienceCompany

Savant HWP - 18-MC Drug Ownership

Who owns Savant HWP - 18-MC Drug?

Savant HWP - 18-MC Drug is owned by Mind Medicine. It was acquired on September 16, 2019.

Savant HWP - 18-MC Drug Business Overview

Where is Savant HWP - 18-MC Drug headquartered?

Savant HWP - 18-MC Drug is headquartered in Reno, Nevada.

What sector is Savant HWP - 18-MC Drug in?

Savant HWP - 18-MC Drug is a life science company.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 249 acquisitions of life science companies in 2019, including 44 acquisitions by private equity firms, and 205 by strategics.

Savant HWP, Inc. - 18-MC Drug

Reno, Nevada 89502
United States,

Savant HWP, Inc. - 18-MC Drug is based on the natural psychedelic substance ibogaine and is focused on addressing the opioid crisis and other forms of addiction. Historically, ibogaine has been successful in treating mostly heroin addicts. 18-MC has been synthesized to be non-hallucinogenic while maintaining ibogaine's anti-addictive properties.


 Subscribe to unlock this and 207,600
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.